SEC Form 4 · accession 0001437749-26-029121
Monopar Therapeutics · MNPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrice Rioux
Other
Period of report
Aug 26, 2026
Accepted (ET)
Aug 27, 2026 · 7:29 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001645469
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 26, 2026 | M | 1,380 | $0.005 | A | 5,066 | D | |
| Common Stock | Aug 26, 2026 | S | 1 | $111.26 | D | 5,065 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $0.005 | Aug 26, 2026 | M | 1,380 | A | — | Dec 14, 2026 | Common Stock | 1,380 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 27, 2026.
- F2On December 15, 2016, the reporting person was granted stock options to purchase up to 1,400 shares of common stock vested: 238 shares on January 15, 2017; 224 shares on February 15, 2017; 238 shares on March 15, 2017; 224 shares on April 15, 2017; 238 shares on May 15, 2017; and 238 shares on June 15, 2017.